| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Digital Pharma Lab [Automatic translation follows] Leading the digital innovation in the healthcare ecosystem We are leading the digital innovation in healthcare. Our mission is to unite healthcare professionals, manufacturers, startups and institutions around digital innovation and collective intelligence. Our approach, unique in Europe, allows all the players in the healthcare ecosystem to undertake, innovate, evolve and participate every day in building the healthcare of tomorrow. Together, beyond the limits 🚀 ______________________________________________________ ______________________________________________________ A pioneer in digital innovation in the healthcare ecosystem, we are a consulting firm dedicated to digital health and the transformation of the healthcare sector through collaboration and collective intelligence. … Sectors: | 209 | 59 | 168 |
 | bioMérieux Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. … Sectors: | 416 | 323 | 63 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3471 | 2589 | 832 |
 | Vetoquinol Global Vetoquinol, your trusted animal health partner for pets and livestock. With a presence amongst the top 10 global veterinary pharmaceutical laboratories, Vetoquinol is first and foremost an independent, family-owned business. Deeply committed to its values, it has always enjoyed a close relationship with its vet clients. Historically based in France, Vetoquinol currently develops, produces and distributes a range of medical and non-medical products and services on the 5 continents. With a presence in 24 countries through its subsidiaries, its strong network of distributor partners provides visibility for its products in more than 80 countries. veterinary, pharmaceutical, nutraceutical, R&D, manufacture, commercialisation, … Sectors: | 24 | 19 | 2 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: | 717 | 383 | 261 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 625 | 378 | 382 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 1073 | 701 | 402 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 829 | 483 | 507 |
 | ANSM Agence nationale de sécurité du médicament et des produits de santé [Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor that allows, on behalf of the State, access to health products in France and ensures their safety throughout their life cycle. At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after it is placed on the market. Through our assessments, our expertise and our monitoring … | 142 | 95 | 32 |
 | MEDICALPS [Automatic translation follows] The Alpine Arc Health Technology Cluster MEDICALPS is the Alpine Arc health technology cluster. Since 2000, the association has brought together and represented a network of more than 130 start-ups, SMEs, large groups, research centers, universities and communities from the fields of medical technologies, biotechnologies and e-health. The leadership of MEDICALPS, facilitator and unifier of this community, is largely entrusted to entrepreneurs, with the support of public stakeholders, with the aim of building the medicine of tomorrow. The association's operational programs serve the growth and visibility of the network of industrialists in the field of health technologies … | 189 | 71 | 141 |
 | EDF Our raison d'être is to build a net zero energy future with electricity and innovative solutions and services, to help save the planet and drive wellbeing and economic development. Energie, Nucléaire, Electricité, Energies renouvelables, and Gaz Sectors: | 4624 | 3832 | 427 |
Health